image by: HWN

HWN Suggests

EPA vs. DHA: Do These Two Omega-3s Actually Do Different Things?

EPA is a precursor to signaling molecules called eicosanoids, which regulate inflammation, immune response, and platelet aggregation. When EPA is incorporated into cell membranes, it competes with arachidonic acid (an omega-6 fatty acid) for the same enzymes, shifting the balance away from pro-inflammatory signaling. This competition mechanism explains why EPA has potent anti-inflammatory effects that show up in markers like high-sensitivity C-reactive protein and inflammatory cytokines. DHA, by contrast, is less involved in acute inflammatory signaling and more involved in structural roles. It's the most abundant omega-3 in the brain, making up roughly 40% of the polyunsaturated fatty acids…

read full article

Featured

 Health Benefits of Eicosapentaenoic Acid (EPA): The Ultimate Guide

Eicosapentaenoic acid isn’t a nutrient you are likely to see on the nutrition facts label of your favorite foods, but it can play a key role in promoting your health. This underrated nutrient can help support everything from your heart health to your immune system, but if you don’t pay attention to it, you are likely missing out on it.

Articles of Interest

Eicosapentaenoic Acid (EPA)

In the world of nutrition, omega-3 fatty acids are often hailed as superheroes, and Eicosapentaenoic Acid (EPA) is no exception. Along with Docosahexaenoic Acid (DHA), EPA plays a vital role in supporting heart health and managing inflammation. You've probably heard about omega-3 fatty acids found in fish oil. Both EPA and DHA are well known for their potential benefits for heart health and inflammation.

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)

Eicosapentaenoic acid, commonly known as EPA, stands out among omega-3 fatty acids for its distinct and powerful contributions to cardiovascular health. As an essential polyunsaturated fatty acid, EPA cannot be produced sufficiently by the human body and must be obtained through diet or supplementation. Its presence is critical for numerous physiological processes, particularly those governing the health and function of the heart and blood vessels. The broad spectrum of Eicosapentaenoic acid cardiovascular benefits stems from its multifaceted actions within the body.

Emerging Pathways of Action of Eicosapentaenoic Acid (EPA)

Substantial randomized data support the cardiovascular benefits of the omega-3 fatty acid eicosapentaenoic acid (EPA). Yet, lack of a clear understanding of the likely multifactorial mechanism of benefit of EPA has generated skepticism among some physicians, potentially leading to underuse of this clinically beneficial, cost-effective, and safe therapy.

EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials

The current meta-analysis provides evidence that EPA may be more efficacious than DHA in treating depression. However, owing to the identified limitations of the included studies, larger, well-designed, randomized controlled trials of sufficient duration are needed to confirm these findings.

EPAs v DHAs – What’s the difference and how do they work?

We’ve all heard the advice to make sure we’re regularly eating servings of good quality fatty fish, but why? What’s all the fuss about omega 3s? Omega-3 fatty acids are polyunsaturated fats, where the ‘3’ refers to the position of the final double bond in the chemical structure (which is three carbon atoms from the “omega,” or tail end of the molecular chain). Two types of omega-3 in particular are plentiful in oily fish: EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid), which are the most thoroughly researched omega 3s.

The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review

A large body of evidence supports the cardioprotective effects of the long-chain omega-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). There is increasing interest in the independent effects of EPA and DHA in the modulation of cardiometabolic risk factors.

The multidimensional benefits of eicosapentaenoic acid: from heart health to inflammatory control

EPA may be a beneficial dietary supplement for people with heart disease risk factors. EPA may help with cardiovascular disease, diabetes, obesity, cancer, and stroke. Inflammation, cholesterol, blood pressure, blood clots, and coronary artery function are all reduced by EPA. EPA reduces inflammation and improves body composition, both of which aid in weight loss. More research is needed, however, to understand how EPA benefits diabetes and obesity. The optimal daily dose of EPA and DHA for health benefits requires more research.

The Power of Omega-3s with DHA and EPA: Why They Work Better Together—and How Personalized Testing Can Optimize Your Health

Omega-3s are polyunsaturated fatty acids that your body cannot produce in sufficient amounts—we must get them from diet or supplements. They are essential for building cell membranes, supporting inflammation regulation, and promoting optimal brain and heart health. DHA: Primarily found in brain and eye tissue, DHA supports cognitive function, memory, and visual development. EPA: Known for its anti-inflammatory properties, EPA helps reduce inflammation, support cardiovascular health, and maintain balanced immune responses.

The Undulating Life of Omega-3 Fatty Acids

The cardiovascular protective effects of omega-3 fatty acids are still under intense debate. Recent results from the Long-Term Outcomes Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia (STRENGTH), which enrolled 13,078 patients with high cardiovascular risk and high prevalence of diabetes, showed that 4 g per day of omega-3 carboxylic acids (a final concentration of 75% of eicosapentaenoic acid [EPA] and docosahexaenoic acid) did not reduce cardiovascular events in high-risk patients. Interestingly, in subgroup analysis, Asian populations obtained cardiovascular benefit, but this result may not have been brought to the attention of the authors.

Resources

Biocrates

Eicosapentaenoic acid (EPA) is a long-chain omega-3 polyunsaturated fatty acid (PUFA) and a precursor to many lipid signaling molecules involved in inflammation and cardiometabolic regulation. The name reflects its structure: “eicosa” refers to its 20 carbon atoms, while “pentaenoic” refers to five double bonds.